Table 1 Clinicopathological characteristics of 215 patients wi1th colorectal cancer after surgery.
Variable | ALL (215) | Low mCXI (60) | High mCXI (155) | P value |
|---|---|---|---|---|
Age (years) | 58.4 ± 12.8 | 60.0 ± 14.4 | 57.8 ± 12.1 | 0.268 |
Male sex, n (%) | 124 (57.7%) | 29 (48.3%) | 95 (61.2%) | 0.085 |
BMI (kg/m2) | 22.9 ± 3.2 | 22.1 ± 3.5 | 23.2 ± 3.1 | 0.02 |
SMI (cm2/m2) | 43.1 ± 4.3 | 40.6 ± 4.7 | 44.1 ± 3.7 | <0.01 |
WBC (×109/L) | 5.8 ± 1.9 | 6.1 ± 2.0 | 5.7 ± 1.8 | 0.191 |
Neutrophil (×109/L) | 3.7 ± 1.8 | 4.6 ± 2.5 | 3.4 ± 1.3 | <0.01 |
Lymphocyte (×109/L) | 1.6 ± 0.6 | 1.2 ± 0.6 | 1.7 ± 0.6 | <0.01 |
Platelet (×109/L) | 216.9 ± 83.7 | 213.0 ± 101.0 | 218.4 ± 77.8 | 0.674 |
Hemoglobin (g/L) | 122.7 ± 24.6 | 117.0 ± 24.3 | 124.9 ± 24.4 | 0.035 |
Total cholesterol | 4.3 ± 1.1 | 4.2 ± 1.2 | 4.4 ± 1.0 | 0.182 |
Albumin (g/L) | 41.3 ± 4.3 | 39.8 ± 5.4 | 41.9 ± 3.7 | 0.007 |
Creatinine | 65.5 ± 18.0 | 59.9 ± 18.9 | 67.7 ± 17.1 | 0.004 |
Blood urea nitrogen | 5.2 ± 1.5 | 5.7 ± 2.2 | 5.0 ± 1.2 | 0.021 |
CRP (mg/L) | 8.6 ± 19.8 | 13.1 ± 26.1 | 6.9 ± 16.5 | 0.085 |
CEA (ng/ml) | 5.9 ± 10.1 | 5.2 ± 5.7 | 6.2 ± 11.4 | 0.493 |
CA199 (U/ml) | 24.8 ± 54.6 | 18.7 ± 26.2 | 27.2 ± 62.2 | 0.305 |
Tumor site, n (%) | 0.350 | |||
Colon | 122 (56.7%) | 31 (51.7%) | 91 (58.7%) | |
Rectum | 93 (43.3%) | 29 (48.3%) | 64 (41.3%) | |
Comorbidities, yes, n (%) | 69 (32.1%) | 17 (28.3%) | 52 (33.5%) | 0.463 |
Postoperative complications, yes, n (%) | 34 (15.8%) | 9 (15.0%) | 25 (16.1%) | 0.839 |
Surgical method | 0.874 | |||
Open | 49 (22.8%) | 16 (26.7%) | 43 (27.7%) | |
Laparoscopy | 156 (77.2%) | 44 (73.3%) | 112 (72.3%) | |
Tumor size (cm) | 4.1 (1.8 ± 0.1) | 4.3 (2.0 ± 0.3) | 4.086 (1.8 ± 0.1) | 0.617 |
Depth of invasion | 0.835 | |||
T1–2 | 45 (20.9%) | 12 (20%) | 33 (21.3%) | |
T3–4 | 170 (79.1%) | 48 (80%) | 122 (78.7%) | |
CRC stage, n (%) | 0.907 | |||
I | 36 (16.7%) | 9 (15.0%) | 27 (17.4%) | |
II | 89 (41.4%) | 25 (41.7%) | 64 (41.3%) | |
III | 90 (41.9%) | 26 (43.3%) | 64 (41.3%) |
